L-Cysteine HCl

CAS No. 52-89-1

L-Cysteine HCl ( L-Cysteine hydrochloride? )

Catalog No. M21191 CAS No. 52-89-1

L-Cysteine HCl is a conditionally essential amino acidL-Cysteine hydrochloride suppresses ghrelin and reduces appetite in rodents and humans.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 Get Quote
1G 43 Get Quote

Biological Information

  • Product Name
    L-Cysteine HCl
  • Note
    Research use only not for human use.
  • Brief Description
    L-Cysteine HCl is a conditionally essential amino acidL-Cysteine hydrochloride suppresses ghrelin and reduces appetite in rodents and humans.
  • Description
    L-Cysteine HCl is a conditionally essential amino acidL-Cysteine hydrochloride suppresses ghrelin and reduces appetite in rodents and humans.
  • Synonyms
    L-Cysteine hydrochloride?
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    others
  • Research Area
    ——
  • Indication
    Erythropoietic Protoporphyria

Chemical Information

  • CAS Number
    52-89-1
  • Formula Weight
    157.62
  • Molecular Formula
    C3H8ClNO2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:31 mg/mL (196.67 mM)
  • SMILES
    Cl.NC(CS)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.McGavigan AK et al. L-cysteine suppresses ghrelin and reduces appetite in rodents and humans. Int J Obes (Lond). 2015 Mar;39(3):447-55.
molnova catalog
related products
  • 1-Methyl-2-pentyl-4(...

    1-Methyl-2-pentyl-4(1H)-quinolinone is a natural product.

  • 2-Aminoisobutyric ac...

    Aminoisobutyric acid is a nonprotein amino acid (is an end product of pyrimidine metabolism) excreted in the urine of about 5% of healthy individuals and high excretion is an autosomal recessive phenotype.

  • Phytolaccagenin

    Phytolaccagenin, a triterpenoid saponin, is the active component of Radix Phtolaccae which are widely used in East Asian countries for the treatment of inflammation-related diseases.